SCTX — Scribe Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1853921 ·
Last close
$15.77
Market Cap
$298.64M
52W High
$39.60
52W Low
$13.50
ADV30
365,516
Next earnings
2026-11-12
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,918,000 — -9,395,000 -6,477,000 57,927,000 35,586,000 222,773,000
Mar 2026 2,233,000 — -12,427,000 -17,347,000 65,208,000 20,381,000 223,946,000
Jun 2025 4,898,000 — -11,627,000 -9,903,000 — — —
Mar 2025 17,125,000 — -5,557,000 -3,425,000 — — —

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-33,144,000
Investing CF
$61,049,000
Financing CF
$-1,737,000
CapEx
$-957,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.54
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-181,531,000
Inventory
—
Receivables
$1,231,000
ST Investments
$7,423,000
EBIT TTM
$-35,669,000
Pretax Income TTM
$-37,739,000
Interest Exp TTM
$2,070,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$14,825,000
EBITDA
$-40,925,000
Free Cash Flow
—
Enterprise Value
$140,728,816
Total Cash
$174,230,000
Total Debt
$5,141,000
Shares Out
18,937,519
Trailing EPS
$-3.84
Book Value
$6.61
ROE
—
ROA
—
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 51,174,000 -26,070,000 -21,808,000 78,219,000 221,638,000 -143,419,000 -45,213,000
Dec 2024 27,413,000 -42,829,000 -47,786,000 127,971,000 253,830,000 -125,859,000 -45,235,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$57,927,000
Forward EPS
$-3.37

Peers — same industry

TickerNameMarket CapLastDaily %
KYTX Kyverna Therapeutics, Inc. $297.14M $4.70 —
AGMB AgomAb Therapeutics NV $291.55M $5.92 —
AUTL Autolus Therapeutics plc $290.12M $1.09 —
XFOR X4 Pharmaceuticals, Inc $315.53M $3.09 —
EDIT Editas Medicine, Inc. $281.67M $1.83 —

News headlines (Yahoo Finance, 1h cache)

Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026
2026-11-18 13:00 · Yahoo
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
2026-11-12 21:05 · Yahoo
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
2026-11-05 13:00 · Yahoo
Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026
2026-11-04 13:00 · Yahoo
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
2026-09-22 11:10 · Yahoo
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
2026-09-17 20:09 · Yahoo
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
2026-09-02 20:05 · Yahoo
Scribe Therapeutics to Participate in Upcoming Investor Conferences
2026-09-01 12:00 · Yahoo
Why Is Sanofi (ENXTPA:SAN) Expanding Its R And D Bets In Vaccines And Gene Editing?
2026-11-13 06:15 · Yahoo
Cathie Wood Makes $64 Million Bet on Two Stocks
2026-09-28 19:11 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.